Mirae Asset Global ETFs Holdings
CADL icon

Mirae Asset Global ETFs Holdings’s Candel Therapeutics CADL Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio CADL Stock Details CADL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$368K Buy
35,720
+14,647
+70% +$111K ﹤0.01% 2167
2026
Q1 		$103K Buy
21,073
+1,073
+5% +$5.84K ﹤0.01% 2653
2025
Q4 		$113K Buy
20,000
+538
+3% +$2.89K ﹤0.01% 2621
2025
Q3 		$99.3K Sell
19,462
-2,058
-10% -$11.9K ﹤0.01% 2666
2025
Q2 		$109K Buy
21,520
+4,772
+28% +$24.6K ﹤0.01% 2571
2025
Q1 		$94.6K Buy
16,748
+4,583
+38% +$37.4K ﹤0.01% 2661
2024
Q4 		$106K Buy
12,165
+1,340
+12% +$7.92K ﹤0.01% 2674
2024
Q3 		$75K Buy
+10,825
New +$67.2K ﹤0.01% 2820

Other funds holding CADL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $2.67B AUM 169.09% 1-Year Est. Return
SVCM
Saturn V Capital Management Austin, Texas $697M AUM 628.57% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's CADL Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings increased its Candel Therapeutics (CADL) stake by 70% in Q2 2026, buying an estimated $111K and bringing the position to 35,720 shares worth $368K. The position accounts for ﹤0.01% of the portfolio, ranked #2167.

Mirae Asset Global ETFs Holdings first reported a position in CADL in Q3 2024 and has held it in 8 quarters since. 138 funds tracked by Wall St. Rank hold CADL as of Q2 2026.

  • Mirae Asset Global ETFs Holdings held 35,720 shares of Candel Therapeutics worth $368K as of Q2 2026.
  • Mirae Asset Global ETFs Holdings bought 14,647 Candel Therapeutics shares in Q2 2026, an estimated $111K.
  • Candel Therapeutics made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #2167 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in Candel Therapeutics in Q3 2024 and has held it in 8 quarters since.
  • 138 funds tracked by Wall St. Rank held Candel Therapeutics as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.